Showing results (41-50 of 68) with videos related to
Sort By:
Pageof 7
ACS Medicinal Chemistry Letters|January 14, 2026
Probing the Chemical Space of Polymerase Theta with Nucleotide Analogues Bearing a Stereogenic All-Carbon Quaternary CenterAmarender Manchoju, Nicole M Duffy, Renaud Zelli, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 25, 2010
Cathepsin K inhibitors prevent bone loss in estrogen-deficient rabbitsBrenda L Pennypacker, Le T Duong, Tara E Cusick, et al.Bioorganic & Medicinal Chemistry Letters|November 16, 2010
Biological activity and preclinical efficacy of azetidinyl pyridazines as potent systemically-distributed stearoyl-CoA desaturase inhibitorsElise Isabel, David A Powell, W Cameron Black, et al.Bioorganic & Medicinal Chemistry Letters|April 6, 2007
Beta-substituted cyclohexanecarboxamide cathepsin K inhibitors: modification of the 1,2-disubstituted aromatic coreJoël Robichaud, Christopher I Bayly, W Cameron Black, et al.Bioorganic & Medicinal Chemistry Letters|June 22, 2011
Applying the pro-drug approach to afford highly bioavailable antagonists of P2Y(14)Joël Robichaud, Jean-François Fournier, Sébastien Gagné, et al.Bioorganic & Medicinal Chemistry Letters|March 20, 2003
3,4-Diaryl-5-hydroxyfuranones: highly selective inhibitors of cyclooxygenase-2 with aqueous solubilityW Cameron Black, Christine Brideau, Chi Chung Chan, et al.Bioorganic & Medicinal Chemistry Letters|September 13, 2005
Trifluoroethylamines as amide isosteres in inhibitors of cathepsin KW Cameron Black, Christopher I Bayly, Dana E Davis, et al.Bioorganic & Medicinal Chemistry Letters|June 12, 2003
Nicotinyl aspartyl ketones as inhibitors of caspase-3Elise Isabel, W Cameron Black, Christopher I Bayly, et al.Bioorganic & Medicinal Chemistry Letters|June 26, 2007
The identification of potent, selective, and bioavailable cathepsin S inhibitorsJacques Yves Gauthier, W Cameron Black, Isabelle Courchesne, et al.Bioorganic & Medicinal Chemistry Letters|November 4, 2011
Nicotinic acids: liver-targeted SCD inhibitors with preclinical anti-diabetic efficacyDavid A Powell, W Cameron Black, Kelly Bleasby, et al.Pageof 7